Comparison of Biodentine and MTA Pulpotomies in the Primary Molar Teeth 3 Year Follow up

• Status: Completed
• Trial end date: 2016-05-30
• Target enrollment: 0
• Participant gender: All

Summary

The aim of this study is to compare two pulpotomy medicaments in primary molars clinically.A total of 200 primary molars with deep caries were treated with two different pulpotomy medicaments (Mineral Trioxide Aggregate and BiodentineTM) in this study. The inclusion criteria for tooth selection were no clinical and radiographic evidence of pulp pathology. During 36 months of follow-up at 3-month intervals, clinical and radiographic success and failures were recorded.

• Phase: Early Phase 1
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Istanbul University

Criteria

Inclusion Criteria:

• no clinical and radiographic evidence of pulp pathology,

• no clinical and radiographic symptoms,

• no history of spontaneous pain and tenderness,

• no percussion, swelling or sinus tracts and pathologic mobility.

Exclusion Criteria:

• any clinical or radiographic evidence of pulp degeneration (spontaneous or nocturnal tooth pain, tenderness to percussion, pathological mobility, internal or external root resorption, swelling or fistula, widened periodontal ligament (PDL)

• furcal or periapical radiolucency teeth requiring more than 5 minutes to achieve hemostasis during clinical procedure.

• without permanent successor